Talphera (TLPH) Stock Price, News & Analysis

+0.02 (+2.11%)
(As of 04/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
32,552 shs
Average Volume
118,270 shs
Market Capitalization
$16.46 million
P/E Ratio
Dividend Yield
Price Target

Talphera MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
518.6% Upside
$6.00 Price Target
Short Interest
0.70% of Float Sold Short
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth
From ($1.12) to ($1.06) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.31 out of 5 stars

Medical Sector

721st out of 909 stocks

Pharmaceutical Preparations Industry

335th out of 423 stocks

TLPH stock logo

About Talphera Stock (NASDAQ:TLPH)

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.

TLPH Stock Price History

TLPH Stock News Headlines

Talphera (NASDAQ:TLPH) Stock Price Up 1.7%
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Week Ahead: Central Banks
See More Headlines
Receive TLPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Previous Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$0.83 per share


Free Float
Market Cap
$16.46 million
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Vincent J. Angotti (Age 56)
    CEO & Director
    Comp: $906.54k
  • Dr. Pamela Pierce Palmer M.D. (Age 61)
    Ph.D., Co-Founder & Chief Medical Officer
    Comp: $699.75k
  • Mr. Raffi Mark Asadorian (Age 55)
    Chief Financial Officer
    Comp: $637.5k
  • Mr. Anil N. Dasu (Age 61)
    Chief Engineering Officer
    Comp: $478.09k

TLPH Stock Analysis - Frequently Asked Questions

Should I buy or sell Talphera stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Talphera in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TLPH shares.
View TLPH analyst ratings
or view top-rated stocks.

What is Talphera's stock price target for 2024?

1 brokerages have issued 12 month target prices for Talphera's stock. Their TLPH share price targets range from $6.00 to $6.00. On average, they expect the company's share price to reach $6.00 in the next year. This suggests a possible upside of 518.6% from the stock's current price.
View analysts price targets for TLPH
or view top-rated stocks among Wall Street analysts.

How have TLPH shares performed in 2024?

Talphera's stock was trading at $0.7989 on January 1st, 2024. Since then, TLPH stock has increased by 21.4% and is now trading at $0.97.
View the best growth stocks for 2024 here

When is Talphera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our TLPH earnings forecast

How were Talphera's earnings last quarter?

Talphera, Inc. (NASDAQ:TLPH) released its quarterly earnings results on Wednesday, March, 6th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.01. The business had revenue of $0.28 million for the quarter.

How do I buy shares of Talphera?

Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TLPH) was last updated on 4/24/2024 by Staff

From Our Partners